| Site-directed non-covalent polymer-drug complexes for inflammatory bowel disease (IBD): formulation development, characterization and pharmacological evaluation SS Kesharwani, R Ahmad, MA Bakkari, MKS Rajput, R Dachineni, ... Journal of Controlled Release 290, 165-179, 2018 | 62 | 2018 |
| The flavonoid metabolite 2, 4, 6-trihydroxybenzoic acid is a CDK inhibitor and an anti-proliferative agent: A potential role in cancer prevention R Sankaranarayanan, CK Valiveti, DR Kumar, SS Kesharwani, T Seefeldt, ... Cancers 11 (3), 427, 2019 | 49 | 2019 |
| Toll-like receptor-4 (TLR4) agonist-based intranasal nanovaccine delivery system for inducing systemic and mucosal immunity MA Bakkari, CK Valiveti, RS Kaushik, H Tummala Molecular pharmaceutics 18 (6), 2233-2241, 2021 | 27 | 2021 |
| Aspirin metabolites 2, 3‑DHBA and 2, 5‑DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention R Sankaranarayanan, CK Valiveti, R Dachineni, DR Kumar, T Lick, ... Molecular medicine reports 21 (1), 20-34, 2020 | 24 | 2020 |
| van slambrouck S R Sankaranarayanan, CK Valiveti, DR Kumar Kesharwani SS, Seefeldt T., Scaria J., Tummala H., Bhat GJ The flavonoid …, 2019 | 5 | 2019 |
| Site-directed polymer-drug complexes for inflammatory bowel diseases (IBD): Formulation development, characterization, and pharmacological evaluation SS Kesharwani, R Ahmad, MA Bakkari, MKS Rajput, R Dachineni, ... Journal of controlled release, 2018 | 2 | 2018 |
| Stable Dietary Ora-Curcumin Formulation Protects from Experimental Colitis and Colorectal Cancer CK Valiveti, B Kumar, AD Singh, SK Biradar, R Ahmad, AB Singh, ... Cells 13 (11), 957, 2024 | | 2024 |
| Polymeric Nanovaccine Delivery System for Influenza Vaccine CK Valiveti South Dakota State University, 2022 | | 2022 |
| Studies on the flavonoid metabolite 2, 4, 6-trihydroxybenzoic acid as a CDK inhibitor and anti-proliferative agent: Potential role in cancer prevention R Sankaranarayanan, CK Valiveti, S van Slambrouck, SS Kesharwani, ... Cancer Research 80 (16_Supplement), 101-101, 2020 | | 2020 |
Siddharth S. Kesharwani, MS (NIPER-...Sanofi US在 sanofi.com 的电子邮件经过验证
Siddharth S. Kesharwani, MS (NIPER-...Sanofi US在 sanofi.com 的电子邮件经过验证
Rakesh DachineniTeva Pharmaceuticals